GlaxoSmithKline (GSK)

1,421.50p
   
  • Change Today:
    -2.00p
  • 52 Week High: 1,497.00
  • 52 Week Low: 1,205.00
  • Currency: UK Pounds
  • Shares Issued: 5,036m
  • Volume: 7,337,610
  • Market Cap: £71,582m
  • RiskGrade: 74
  • Beta: 0.52

Latest ShareCast News

Glaxo to take full control of Cellzome

Date: Tuesday 15 May 2012

Drugs giant GlaxoSmithKline is to take full control of Cellzome, a company specialising in the study of protein structures and functions.

GlaxoSmithKline Regulatory News

Director Declaration 16-May-2012 17:20 RNS
Transaction in Own Shares 16-May-2012 17:15 RNS
GSK increases its ownership in Theravance 16-May-2012 14:12 RNS
Transaction in Own Shares 15-May-2012 17:07 RNS
GSK to fully acquire Cellzome 15-May-2012 10:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,421.50p
Change Today -2.00p
% Change -0.14 %
52 Week High 1,497.00
52 Week Low 1,205.00
Volume 7,337,610
Shares Issued 5,036m
Market Cap £71,582m
Beta 0.52
RiskGrade 74

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.28% below the market average6.28% below the market average6.28% below the market average6.28% below the market average6.28% below the market average
65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average
Price Trend
61.66% above the market average61.66% above the market average61.66% above the market average61.66% above the market average61.66% above the market average
32.14% above the sector average32.14% above the sector average32.14% above the sector average32.14% above the sector average32.14% above the sector average
Income
71.84% above the market average71.84% above the market average71.84% above the market average71.84% above the market average71.84% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Growth
58.31% above the market average58.31% above the market average58.31% above the market average58.31% above the market average58.31% above the market average
55.10% above the sector average55.10% above the sector average55.10% above the sector average55.10% above the sector average55.10% above the sector average

What The Brokers Say

Strong Buy 12
Buy 3
Neutral 17
Sell 3
Strong Sell 0
Total 35
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Special
Ex-Div 09-May-12 15-Feb-12
Paid 05-Jul-12 12-Apr-12
Amount 17.00p 5.00p

Trades for 16-May-2012

Time Volume / Share Price
16:51 5,600 @ 1,421.15p
16:46 435 @ 1,424.00p
16:44 4,003 @ 1,421.25p
16:42 3,000 @ 1,422.06p
16:36 2,500 @ 1,421.50p

GlaxoSmithKline Key Personnel

CEO Andrew P Witty

Top of Page